Piramal Critical Care, a Bethlehem, Pa.-based integral business unit of Piramal Enterprises, and Nashville-based specialty pharmaceutical company Cumberland Pharmaceuticals Inc. have launched co-promotion of two of Cumberland’s branded hospital products, Caldolor® and Vaprisol® throughout the United States.
Caldolor (ibuprofen) Injection is the first injectable product approved in this country for the treatment of pain and fever in adults. The brand recently received FDA approval for the management of pain and reduction of fever use in pediatric patients six months and older. Vaprisol is the only injectable brand available to treat hyponatremia, the most common electrolyte imbalance in U.S. hospitalized patients.
Piramal will help expand Cumberland’s reach for these products by providing coverage to an additional group of hospitals where Piramal’s critical care sales force has existing relationships.
NeuroMed TMS Centers Opens Nashville Office
NeuroMed TMS Centers recently opened a Nashville office on West End Avenue, bringing Deep TMS to the area. Transcranial Magnetic Stimulation is an FDA approved treatment for depression. While TMS has been around since 2008, the new “Deep TMS” technology developed by manufacturer, Brainsway Ltd., enables patients to spend half the time in the treatment process with better results. In 2015 most major insurance carriers activated policies to cover TMS treatment.